NCT05990231 2023-09-11
Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Unknown